The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Insulin (Human Mixtard 30) is a hormone produced ...

The withdrawal of Mixtard 30 by pharmaceutical manufacturer Novo Nordisk at the end of this year is expected to cause a great deal of confusion and extra expense to people suffering from diabetes as ...

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add £9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

A popular diabetes drug used by thousands will no longer be available in the UK but doctors are concerned by the effects on both their patients and the added financial burden on the NHS. Until very ...

Pharmaceutical giant Novo Nordisk is discontinuing the country's largest selling insulin, Human Mixtard, along with other insulins. The move could shake up the diabetes market, TOI reported. Despite ...

Novo Nordisk’s insulin brand Mixtard will continue to be available in vials, the Danish healthcare company clarified, even as it phases out its penfill. The penfill is being phased out as part of ...

Mixtard 30 to be discontinued in December Mixtard 30 insulin products are to be discontinued by Novo Nordisk on 31 December, the company has announced.

Denmark-based global pharma major, Novo Nordisk is now phasing out its Human Mixtard penfill by the year end. However Mixtard in India will continue to be available in vials. Along with it, other form ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Actrapid®, Protaphane®, or Mixtard® Penfill®?

Drug company Novo Nordisk's decision to pull its Mixtard 30 insulin drug from the UK could add GBP9 million to the NHS drugs bill in England alone, says an editorial in the Drug and Therapeutics ...